Mitochondrial disorders are now recognised as a significant cause of inherited disease. Progress toward new treatments relies on strong collaboration between clinicians, lab-based researchers, and the life sciences industry, grounded in a deep understanding of disease mechanisms. This conference is designed to bring these communities together.
The programme will focus on fostering new partnerships to translate mechanistic insights into effective therapies for mitochondrial diseases. A dedicated panel discussion will examine current challenges, opportunities, and insights gained from clinical trial experience.
Bringing together international experts across genomics, biochemistry, pathology, and clinical medicine, the meeting will unite leaders in mitochondrial research with early-career scientists. The agenda includes invited talks, oral presentations selected from abstracts, poster sessions, poster pitches, and structured networking, creating a dynamic and collaborative environment.